Radiotheranostics in oncology: Making precision medicine possible

Cited by (131)

Items 101–131 of 131

1. Handlungsempfehlungen und Maßnahmen
   Julia Krieger, Fabian Berkemeier, Stephanie Sussmann · 2025 · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks
2. Eine Versorgungsanalyse zur Radioligandentherapie am Beispiel des Prostatakarzinoms
   Julia Krieger, Fabian Berkemeier, Stephanie Sussmann · 2025 · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks
3. Anhang
   Julia Krieger, Fabian Berkemeier, Stephanie Sussmann · 2025 · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks
4. Weißbuch Radioligandentherapie in Deutschland: Eine Bedarfsanalyse und Handlungsempfehlungen für die Nuklearmedizin
   Fabian Berkemeier, Julia Krieger, Stephanie Sussmann · 2025 · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks
5. Hintergrund
   Julia Krieger, Fabian Berkemeier, Stephanie Sussmann · 2025 · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks
6. Radiotheranostics in the era of precision medicine
   Jasmine Sati, Vijayta Dani Chadha · 2025 · Elsevier eBooks
7. Functional Nanohybrids for Solid Tumor Theranostics
   Vivek P. Chavda, Surbhi Koul, Dixa A. Vaghela, Anjali Prashant Bedse, Rohankumar Patel · 2025 · Springer eBooks
8. Piflufolastat F-18, Illuccix, Posluma, Pluvicto, and beyond: the development of radiopharmaceuticals for prostate cancer theranostics
   Feifei An, Jingjing Zhang, Ömer Aras · 2025 · Elsevier eBooks
9. Introduction to theranostics in oncology
   Moushumi Baidya, R Keswani, Shvetank Bhatt · 2025 · Elsevier eBooks
10. Radiopharmaceutical therapy for metastatic prostate cancer: Insights from mechanistic modeling and in silico trials
    Matteo Italia, Silvia Bordel-Vozmediano, José García Otero, Gabriel F. Calvo, Víctor M. Pérez‐García · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
11. Immuno-PET Imaging of Tumor Mesothelin Expression with a Gallium-68 Radiolabeled Nanobody.
    Xiaoying Lv, Yueling Deng, Xiangming Song, Dan-Zha Zheng, Zhao-Guo Lin, Zaijie Wu, Da-Wei Jiang, Yong-Kang Gai, Wei-Jun Wei, Xiao-Li Lan · 2026 · Molecular Pharmaceutics
12. Teranostyka w Europie - współczesna terapia radioligandowa.
    Adriana Budnik, Agata Karolina Pietrzak · 2026 · Letters in Oncology Science
13. Radiotheranostics in solid tumors: focus on radiopharmaceutical therapy and clinical challenges
    Daniela Lucente, Stefania Bellino, Anna La Salvia · 2026 · Expert Review of Anticancer Therapy
14. Radionuclide theranostics: advances and clinical applications in lung cancer
    Yang Yang, Jiang Fu, ShengJie Tang, Tao Liu, Haiyang Hu, Haiyang Guo, Long Wen, YunLong Yang, Chengkuan Liu, Yixin Zhang et al. · 2026 · Frontiers in Oncology
15. Emerging Technologies and Approaches
    Sayani Ghosh, Sunny Kumar, Mrinal K. Ghosh · 2026 · Springer eBooks
16. Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions
    Zhiwu Dong, Sixiang Yan, X J Liu, Peng Gu · 2026 · Med Research
17. Development of a Neopentyl Radiohalogen Labeling Aimed at Creating 211At/18F Theranostic Pairs
    Tomoya Uehara, Jun Toyohara, Hiroshi Tanaka · 2026 · Journal of Synthetic Organic Chemistry Japan
18. Translation of a novel EphA2-targeted PET tracer from preclinical models to first-in-human studies in pancreatic cancer
    Xinyu Liu, Li Sun, Jialiang Lei, Liyan Bai, Haoyao Guo, Yichong Fang, Jianping Zhang, Chunjuan Jiang, Xiaoping Xu, Shaoli Song · 2026 · European Journal of Nuclear Medicine and Molecular Imaging
19. Dynamic precision oncology: from static mutation matching to adaptive tumor–host ecosystems
    Takehiro Okabayashi, Ryo Inada, Motoyasu Tabuchi, Nobuo Takata, Naoki Mimura · 2026 · Expert Review of Anticancer Therapy
20. Expanding CAM Models: In Vivo PET/CT Imaging of Cancer Xenografts on the Ostrich CAM
    Marta Pomraenke, Julia Greiser, Olga Perkas, Lukas M. Zehner, Valentin D. Wegner, Nikolaus Gaßler, Alexander Sandy Mosig, K Huebner, Regine Schneider‐Stock, Nassim Ghaffari‐Tabrizi‐Wizsy et al. · 2026 · ACS Applied Bio Materials
21. Dual-Targeted Radionuclide Therapy with 161Tb Instigates Anticancer Immunity in “Cold” Murine Prostate Tumor
    Juan Sun, Jiakun Guo, Xunhao Qi, Jiangtao Yang, Guanglin Wang, Guangming Zhou, Fenghua Meng, Zhiyuan Zhong · 2026 · Molecular Pharmaceutics
22. Radiology in Cancer Research
    Erez Klein, Ghassan El-Haddad, Vaiva Gustainyte, Hakob Kocharyan, Altan Ahmed · 2026 · Springer eBooks
23. Best Practices for Treatment Team Collaboration in the Use of Radiopharmaceutical Therapy in the United States
    Philipose Getachew Mulugeta, Ana P. Kiess, Bridget F. Koontz, Nichole M. Maughan, Ka Kit Wong, Hyun Jee Kim · 2026 · JCO Oncology Practice
24. Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes
    Julie Nonnekens, Lauren A. Byers, Aman Chauhan, Daniel J. George, Rodney J. Hicks, Wolfgang Weber · 2026 · Clinical Cancer Research
25. Synthesis, Characterisation and Structural Analysis of Rhenium and Technetium Nitride Complexes With Tridentate Thiosemicarbazone‐Phenols and Phosphine Ligands: Potential Applications in Technetium‐99m Radiotracer Development
    Nicola Salvarese, Davide Lucchini, Carolina Gobbi, Marco Baron, Dominga Rogolino, Mauro Carcelli, Alessandro Dolmella, Cristina Bolzati · 2026 · Bioinorganic Chemistry and Applications
26. Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [225Ac]Ac-DOTATATE therapy
    Ya Liu, Tingting Xu, Hongyu Yang, Zhanwen Huang, Haoyuan Ding, Yu Zhang, Yue Chen · 2026 · European Journal of Nuclear Medicine and Molecular Imaging
27. Albumin-Binding Moieties Tune the Pharmacokinetics and Tumor Uptake of 177Lu-Labeled GRPR Radioligands
    Karim Obeid, Esther Olaniran Håkansson, Ekaterina Bezverkhniaia, Bobo Skillinghaug, Ulrika Rosenström, Panagiotis Kanellopoulos, Anna Orlova, Luke R. Odell · 2026 · ACS Medicinal Chemistry Letters
28. Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges
    Weirong Shi, Limin Zhang, Xinyue Feng, Jiayu Liu, Xinru Li, Xueming Dong, Andrea Li‐Ann Wong, Xiaoguang Chen, Lingzhi Wang, Boon-Cher Goh · 2026 · Frontiers in Pharmacology
29. Evolution of Aggregation-Induced Emission Materials in Cancer Diagnosis and Therapy: Toward Clinical Translation
    Qi Li, Guo Zhao, Hanchen Shen, Z H Huang, Tingyi Chen, Mengyue Shi, Tianfu Zhang, Ben Zhong Tang, Shipeng Ning · 2026 · Accounts of Chemical Research
30. Targeted radioligand therapy in oncology: clinical development across targets and platforms
    Jiaxin An, Xiaolei Meng, Lara Hathout, Ronald D. Ennis, Xinxin Zhang, Ning Jeff Yue, Matthew Pierre Deek, Salma K. Jabbour · 2026 · Frontiers in Oncology
31. Small-Molecule Phototheranostics: A Decade of Molecular Design, Advances, and Future Perspectives
    Ananya Sharma, Anirban Das, Sanhita Sinharay · 2026 · ACS Bio & Med Chem Au